LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
YETI Holdings
YETI
DexCom
DXCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 69.00%25.05M | -62.85%8.29M | 0.53%12.05M | 37.49%44.34M | -125.88%-4.79M | 26.45%14.82M | 2,831.95%22.32M | 320.05%11.98M | -29.31%32.25M | -4.21%18.49M |
Other non cashItems | 39.88%-4.28M | 50.03%-3.7M | -24.10%-7.35M | -81.05%-25.58M | -28.59%-5.15M | -291.57%-7.11M | -72.12%-7.4M | -47.68%-5.92M | -37.62%-14.13M | -51.25%-4.01M |
Change in working capital | 11.13%2.79M | -139.45%-802K | 80.04%5.03M | 74.45%5.77M | -218.28%-1.57M | 420.05%2.51M | 560.06%2.03M | 13.75%2.8M | 793.78%3.31M | 153.66%1.32M |
-Change in receivables | 354.76%107K | 2.26%1.09M | 450.49%1.42M | 108.60%497K | 95.39%-117K | 98.46%-42K | 777.69%1.06M | 36.16%-406K | -1,820.93%-5.78M | -121.11%-2.54M |
-Change in other current assets | -55.78%134K | 173.37%503K | -78.26%60K | -88.99%25K | 10.33%-738K | 0.33%303K | -33.33%184K | -41.53%276K | 137.90%227K | ---823K |
-Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -74.71%25.92M | -142.88%-38.65M | 470.28%68.6M | 131.25%112.44M | 68.51%-61.64M | 212.51%102.49M | 267.80%90.12M | 4.07%-18.53M | -487.54%-359.85M | -195.66%-195.73M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | 93.46%-7M | 294.59%72M | -200.00%-35M | -108.36%-40M | -67.72%69M | -195.11%-107M | -148.05%-37M | -53.33%35M | 2,756.94%478.25M | 21,275.00%213.75M |
Net commonstock issuance | ---6.73M | ---12.84M | ---10.61M | --0 | --0 | --0 | --0 | --0 | -109.07%-10.82M | -101.50%-1.51M |
Cash dividends paid | 4.84%-17.35M | -1.68%-18.54M | -4.45%-19.04M | -42.12%-73.32M | -27.75%-18.64M | -35.52%-18.23M | -47.22%-18.23M | -63.15%-18.23M | -187.46%-51.59M | -41.00%-14.59M |
Net other financing activities | ---1K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -79.94%-44.76M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 75.17%-31.11M | 172.85%40.54M | -503.17%-64.65M | -131.93%-115.23M | -74.62%49.67M | -239.11%-125.28M | -197.62%-55.65M | -11.52%16.04M | 606.88%360.91M | 179.75%195.72M |
Net cash flow | ||||||||||
Beginning cash position | -76.66%8.81M | 111.40%6.92M | -48.45%2.97M | 22.65%5.76M | 158.83%14.95M | 454.19%37.74M | -6.81%3.27M | 22.65%5.76M | -68.45%4.7M | 516.55%5.77M |
Current changes in cash | 77.22%-5.19M | -94.50%1.9M | 258.43%3.95M | -362.31%-2.79M | -92,015.38%-11.98M | -2,100.29%-22.8M | 944.52%34.47M | -109.77%-2.49M | 110.44%1.06M | -100.35%-13K |
End cash position | -75.80%3.62M | -76.66%8.81M | 111.40%6.92M | -48.45%2.97M | -48.45%2.97M | 158.83%14.95M | 454.19%37.74M | -6.81%3.27M | 22.65%5.76M | 22.65%5.76M |
Free cash flow | -74.71%25.92M | -142.88%-38.65M | 470.28%68.6M | 131.25%112.44M | 68.51%-61.64M | 212.51%102.49M | 267.80%90.12M | 4.07%-18.53M | -487.54%-359.85M | -195.66%-195.73M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |